{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:54:20Z","timestamp":1785902060799,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004742","name":"National Academy of Sciences of Ukraine","doi-asserted-by":"publisher","award":["2.1.10.18\\u201324"],"award-info":[{"award-number":["2.1.10.18\\u201324"]}],"id":[{"id":"10.13039\/501100004742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmcl.2025.130474","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:09:38Z","timestamp":1763608178000},"page":"130474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Investigation of the combinatorial anticancer effects of imidazolium-based ionic liquids and lysosomotropic detergents with cisplatin and doxorubicin"],"prefix":"10.1016","volume":"131","author":[{"given":"Anastasiia","family":"Gryniukova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy","family":"Rogalsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petro","family":"Borysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Hodyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasyl","family":"Kovalishyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larysa","family":"Metelytsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bmcl.2025.130474_bb0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of Cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130474_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.842114","article-title":"Editorial: combinatorial approaches for Cancer treatment: from basic to translational research","volume":"12","author":"Cerrato","year":"2022","journal-title":"Front Oncol"},{"issue":"7782","key":"10.1016\/j.bmcl.2025.130474_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130474_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7530794","article-title":"Radiotherapy\/chemotherapy-immunotherapy for Cancer management: from mechanisms to clinical implications","author":"Li","year":"2023","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130474_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s43856-025-00991-8","article-title":"Drug combination-wide association studies of cancer","volume":"5","author":"Lalagkas","year":"2025","journal-title":"Commun Med"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130474_bb0030","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2025.36.e10","article-title":"Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy in patients with locally advanced cervical squamous cell carcinoma","volume":"36","author":"Feng","year":"2025","journal-title":"J Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130474_bb0035","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130474_bb0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2004.09.038","article-title":"Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma","volume":"96","author":"Mitsuhashi","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"15","key":"10.1016\/j.bmcl.2025.130474_bb0045","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130474_bb0050","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1007\/s11030-023-10779-4","article-title":"Anticancer activity features of imidazole-based ionic liquids and lysosomotropic detergents: in silico and in vitro studies","volume":"28","author":"Gryniukova","year":"2024","journal-title":"Mol Divers"},{"issue":"W1","key":"10.1016\/j.bmcl.2025.130474_bb0055","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"10.1016\/j.bmcl.2025.130474_bb0060","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.3390\/molecules27144478","article-title":"Doxorubicin-based hybrid compounds as potential anticancer agents: a review","volume":"27","author":"Peter","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130474_bb0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/2141-9248.126619","article-title":"An evaluation of hepatotoxicity in breast cancer patients receiving injection doxorubicin","volume":"4","author":"Damodar","year":"2014","journal-title":"Ann Med Health Sci Res"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130474_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/03602532.2011.609174","article-title":"Possibilities to increase the effectiveness of doxorubicin in cancer cells killing","volume":"43","author":"Hanu\u0161ov\u00e1","year":"2011","journal-title":"Drug Metab Rev"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130474_bb0075","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1039\/C8CP06776G","article-title":"Molecular mechanism and binding free energy of doxorubicin intercalation in DNA","volume":"21","author":"Jawad","year":"2019","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.bmcl.2025.130474_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.04.009","article-title":"Structural modifications in the sugar moiety as a key to improving the anticancer effectiveness of doxorubicin","volume":"178","author":"Denel-Bobrowska","year":"2017","journal-title":"Life Sci"},{"issue":"21","key":"10.1016\/j.bmcl.2025.130474_bb0085","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1111\/febs.15583","article-title":"New insights into the activities and toxicities of the old anticancer drug doxorubicin","volume":"288","author":"van der Zanden","year":"2021","journal-title":"FEBS J"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130474_bb0090","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/ijms23031532","article-title":"Pharmacological effects of cisplatin combination with natural products in Cancer chemotherapy","volume":"23","author":"Dasari","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130474_bb0095","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41598-020-80876-z","article-title":"New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130474_bb0100","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1747493018778713","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int J Stroke"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130474_bb0105","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/acs.molpharmaceut.8b00864","article-title":"In vitro cytotoxicity and interaction of noscapine with human serum albumin: effect on structure and esterase activity of HSA","volume":"16","author":"Maurya","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2025.130474_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.115159","article-title":"Noscapine anticancer drug designed with ionic liquids to enhance solubility: DFT and ADME approach","volume":"325","author":"Kumar","year":"2021","journal-title":"J Mol Liq"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130474_bb0115","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1007\/s12010-014-0813-6","article-title":"Recent advances in the applications of ionic liquids in protein stability and activity: a review","volume":"172","author":"Patel","year":"2014","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130474_bb0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/acs.molpharmaceut.3c00673","article-title":"Development of Cholinium-based API ionic liquids with enhanced drug solubility: biological evaluation and interfacial properties","volume":"21","author":"Bhat","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2025.130474_bb0125","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s11696-025-03972-2","article-title":"Augmenting nisin antibacterial activity: in-vitro analysis with 1-alkyl-1-methylpyrrolidin-1-ium bromide","volume":"79","author":"Saraswat","year":"2025","journal-title":"Chem Pap"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500383X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500383X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:34:29Z","timestamp":1780914869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2500383X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"alternative-id":["S0960894X2500383X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130474","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the combinatorial anticancer effects of imidazolium-based ionic liquids and lysosomotropic detergents with cisplatin and doxorubicin","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130474"}}